Clinical Significance and Prognostic Impact of Subcutaneous or Intrastrap Muscular Recurrence of Papillary Thyroid Carcinoma

Table 3

Clinical courses for 29 PTC patients showing SIM recurrence.

*Was this the initial recurrence?
Yes; No	19 (66%); 10 (34%)
Repeated SIM recurrence
Yes; No	5 (17%); 24 (83%)
Recurrence at other sites
Yes; No	17 (59%); 12 (41%)
Other local recurrences
Yes; No	15 (52%); 14 (48%)
Distant recurrences
Yes; No	13 (45%); 16 (55%)
Clinical outcomes
Death of PTC; Alive with PTC; Alive without PTC	3 (10%); 10 (34%); 16 (56%)

*Including patients whose other recurrenceswere detected at the same time.